Bicycle Therapeutics PLC (BCYC) stock
BCYCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 11/3079% below fair value
$3.37−0.08 (-2.32%)
Close on Nov 13, 2026Market cap $236.22MP/E –Yield 0.00%
Bicycle Therapeutics statistics
83 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Mar 16, 2027 (estimated, before the open)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 0.47
- 2.22
Enterprise valuationIndustry
- EV / Sales
- -2.80
- 2.57
Share statisticsIndustry
- Shares Change (YoY)
- 0.70%
- 10.8%
- Shares Change (QoQ)
- 0.26%
- 0.50%
- Float
- 55M
- 49M
- Shares Held by Insiders
- 21.3%
- 11.7%
- Shares Held by Institutions
- 53.4%
- 56.4%
Short sellingIndustry
- Short Interest
- 4M
- –
- Short Interest Change
- 11.7%
- -0.80%
- Days to Cover
- 8.38
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $7.83
- –
- 52-Week Low
- $3.26
- –
- 20-Day Moving Average
- $3.64
- –
- 50-Day Moving Average
- $3.70
- –
- 200-Day Moving Average
- $4.41
- –
- Average True Range (14)
- $0.20
- –
- Price Change (1 Week)
- -6.65%
- -1.15%
- Price Change (1 Month)
- -6.39%
- -4.87%
- Price Change (3 Months)
- -15.8%
- -21.0%
- Price Change (6 Months)
- -24.3%
- -20.6%
- Price Change (YTD)
- -52.4%
- -23.6%
- Price Change (1 Year)
- -48.6%
- -22.4%
- Price Change (3 Years)
- -77.1%
- -29.5%
- Price Change (5 Years)
- -94.2%
- -77.9%
- Average Volume (10 Days)
- 361,157
- –
- Average Volume (20 Days)
- 410,824
- –
- Average Volume (90 Days)
- 393,645
- –
- Relative Volume
- 1.54
- 0.70
- Relative Strength Index (14)
- 40.0
- 43.4
- Volatility (1 Year)
- 50.7%
- 80.1%
- Beta (5 Years)
- 1.37
- 1.07
MarginsIndustry
- Pretax Margin
- -166.5%
- -11.6%
- EBITDA Margin
- -183.8%
- -27.7%
- FCF Margin
- -211.9%
- -9.56%
Returns on capitalIndustry
- Return on Equity (ROE)
- -25.2%
- -49.9%
- Return on Assets (ROA)
- -21.3%
- -40.6%
- Return on Invested Capital (ROIC)
- -4542.9%
- -32.9%
- Return on Capital Employed (ROCE)
- -30.3%
- -37.9%
Financial positionIndustry
- Current Ratio
- 12.09
- 3.30
- Quick Ratio
- 10.57
- 2.39
- Interest Coverage
- -815.60
- -6.35
GrowthIndustry
- Revenue Growth (YoY)
- 194.7%
- 6.82%
- Revenue Growth (3Y CAGR)
- 71.2%
- 2.25%
- Revenue Growth (5Y CAGR)
- 47.5%
- 6.41%
EfficiencyIndustry
- Asset Turnover
- 0.13
- 0.40
- Revenue Per Employee
- $290.03K
- $429.29K
- Profits Per Employee
- -$492.33K
- -$689.41K
- Employee Count
- 288
- 74
- WACC
- 12.0%
- 10.2%
Income statement (TTM)Industry
- Pretax Income
- -$139.09M
- -$12.95M
Balance sheetIndustry
- Net Cash (Debt)
- $469.93M
- $17.76M
- Net Cash Per Share
- $6.70
- $0.80
- Equity (Book Value)
- $505.28M
- $53.89M
- Book Value Per Share
- $7.21
- $1.50
- Tangible Book Value
- $505.28M
- $27.13M
- Working Capital
- $493.10M
- $79.99M
Cash flow (TTM)Industry
- Capital Expenditures
- -$1.86M
- -$1.00M
- FCF Per Share
- -$2.53
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- -60.0%
- -21.8%
- FCF Yield
- -74.9%
- -9.44%
- Dividend Yield
- 0.00%
- 1.88%
- Shareholder Yield
- 0.00%
- 0.00%
- Dividend Per Share
- $0.00
- $0.83
- Years of Dividend Growth
- 0
- 0
Taxes and interestIndustry
- Interest Expense
- $194.00K
- $2.90M
- Income Tax
- $2.70M
- $73.00K
Scores and fair valueIndustry
- Altman Z-Score
- 0.04
- 0.23
- Piotroski F-Score
- 2
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | BCYC | S&P 500 | Difference | BCYC per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -7.2% | -3.0% | −4.1 pts | ||
| 3 months | -15.3% | -2.8% | −12.5 pts | ||
| Year to date | -52.4% | +11.5% | −63.9 pts | ||
| 1 year | -48.9% | +13.5% | −62.4 pts | ||
| 3 years | -75.4% | +77.7% | −153.1 pts | -37.4% | +21.1% |
| 5 years | -94.2% | +72.6% | −166.8 pts | -43.4% | +11.5% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
4M BCYC shares were sold short on Oct 30, 2026, up 11.7% from the previous report. At recent volumes it would take 8.4 days to buy them back. Over the last 20 sessions, 55.5% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 3,858,686 | +11.7% | 460,266 | 8.4 |
| Oct 15, 2026 | 3,453,064 | +4.5% | 554,332 | 6.2 |
| Sep 30, 2026 | 3,302,888 | -0.9% | 378,570 | 8.7 |
| Sep 15, 2026 | 3,331,791 | +1.5% | 499,132 | 6.7 |
| Aug 31, 2026 | 3,281,399 | +1.8% | 238,343 | 13.8 |
| Aug 14, 2026 | 3,224,453 | +8.1% | 315,919 | 10.2 |
| Jul 31, 2026 | 2,983,889 | +0.0% | 301,853 | 9.9 |
| Jul 15, 2026 | 2,982,919 | +3.4% | 388,193 | 7.7 |
| Jun 30, 2026 | 2,883,802 | +2.1% | 606,609 | 4.8 |
| Jun 15, 2026 | 2,825,596 | -1.3% | 648,641 | 4.4 |
| May 29, 2026 | 2,861,415 | +5.9% | 264,671 | 10.8 |
| May 15, 2026 | 2,701,708 | -7.7% | 356,676 | 7.6 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?